People show up to this topic thinking they have to pick a team. Either you are committed to abstinence (the "real" recovery) or you are doing harm reduction (which gets misread as giving up). The people who work in this field know that framing is wrong, but somehow it has not quite reached the rest of the culture.
Here is the actual picture.
What each one is, briefly
Abstinence is not drinking, not using, and usually not using any mood-altering substance including non-prescribed medications. It is the goal of some recovery programs (most famously Alcoholics Anonymous and Narcotics Anonymous) and is clinically appropriate for many situations, especially when someone has a severe substance use disorder or when continued use is medically contraindicated.
Harm reduction is a set of public-health strategies aimed at reducing the negative consequences of substance use for people who are still using. It includes things like naloxone distribution, syringe services, fentanyl test strips, never-use-alone hotlines, safer-use education, and medications like buprenorphine or naltrexone that can be started without requiring abstinence first.
The US federal government adopted harm reduction as part of its formal continuum of care in 2023, when the Substance Abuse and Mental Health Services Administration published its Harm Reduction Framework. The CDC and HHS Overdose Prevention Strategy follow the same framing.
Why they are not opposites
The argument that harm reduction is opposed to abstinence rests on the idea that keeping people who use drugs alive and healthier enables use, which delays or prevents recovery.
The research does not support this framing. People in harm reduction programs, syringe services, low-threshold medication programs, overdose prevention services, enter formal substance use treatment at higher rates than matched populations who are not in those programs, not lower. The same has been found for naloxone distribution: the concern that putting naloxone in the hands of people who use opioids would lead to riskier use has been studied and not borne out.
In plain terms: if you keep someone alive this year, they might decide to stop next year. If they die this year, they definitely will not.
What changed in treatment
The idea that harm reduction sits outside "real" treatment is also outdated at the level of clinical practice. Several of the most effective treatment tools in the addiction medicine toolkit are harm-reduction in structure:
- Low-threshold buprenorphine programs treat opioid use disorder without requiring that patients be abstinent from other substances first. This has been repeatedly shown to improve retention and outcomes.
- Naltrexone on the Sinclair method for alcohol use disorder, taking medication before drinking to gradually extinguish the reinforcement loop, is not abstinence-based. Effect sizes are modest but meaningful.
- Moderation Management is a peer support group for people pursuing moderated drinking rather than abstinence, and it is clinically appropriate for mild-to-moderate alcohol use disorder.
None of these disqualify someone from later pursuing abstinence. Many of them make abstinence easier to reach, by stabilizing the person and reducing the acute harms of continued use in the meantime.
When abstinence is the right target
For many people, abstinence is clinically the right goal. Specifically:
- Severe substance use disorders, where moderation has been attempted and has failed repeatedly.
- Opioid use disorder, where continued use carries overdose risk that is not reduced by modest-use strategies, though here, the clinical consensus is that abstinence plus medication (buprenorphine or methadone) is meaningfully different from and safer than abstinence alone.
- Medical contraindications, liver disease with alcohol, pregnancy, certain co-occurring medications.
- Personal preference. Some people, after trying to moderate, land on abstinence as what works for them, and that preference is itself a valid clinical reason to pursue it.
When harm reduction is the right target
- When someone is not ready for abstinence, and making abstinence the precondition for any help means they get no help at all.
- When the goal right now is staying alive, in an era when much of the street opioid supply is contaminated with fentanyl and increasingly with xylazine, overdose prevention is, itself, a legitimate and urgent target.
- When the person has a mild-to-moderate disorder and wants to try moderation first, especially for alcohol, where non-abstinent recovery has been validated in multiple research literatures as a real and stable outcome.
- While someone is working their way toward treatment, harm reduction keeps people alive, healthy, and engaged until they reach that step.
The pivot point most people miss
The actual question is almost never "abstinence or harm reduction." It is almost always:
- What is this person ready for today?
- What is safe for this person today?
- What approach keeps them alive and functioning while we find out what will work over the medium term?
Those answers change over time. Someone might do harm reduction for a year, try a medication, enter outpatient treatment, work toward abstinence, relapse, try moderation, and land in a stable pattern somewhere they did not initially plan to be. That is not failure of the framework. That is how chronic conditions often look when they are treated honestly.
The bottom line
Harm reduction and abstinence are both legitimate strategies with real evidence bases. They serve different moments in different situations, and they often work together in the same person's care over time. If anyone is telling you that you have to pick one forever, or that one is "real recovery" and the other is giving up, that is ideology rather than medicine.
The question worth asking is: what is safest, most sustainable, and most aligned with what I actually want for my life over the next six months? The answer to that question evolves. That is fine. The plan evolves with it.
What to read next
What to read next
Most people with substance use disorders can be treated effectively without residential rehab. Outpatient care, medications, and harm reduction are real options backed by clinical evidence. You do not have to make a permanent decision today. The next step can be small.